Selective Androgen Receptor Degrader (SARD) to Overcome Antiandrogen Resistance in Castration-Resistant Prostate Cancer

Investigators found and identified a bifunctional small molecule Z15, which was both an effective androen receptor (AR) antagonist and a selective AR degrader.